Seroatlas · Human Serome Atlas

ACBD7

Acyl-CoA-binding domain-containing protein 7

Also known as: ACBD7_HUMAN, bA455B2.2, FLJ38219

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8N6N7
Gene
ACBD7
Ensembl
ENSG00000176244
Chromosome
10
Canonical length
88 aa
Protein class
Predicted intracellular proteins
Subcellular location
Vesicles,Cytosol

OverviewNCBI Gene

Predicted to enable fatty-acyl-CoA binding activity. Predicted to be involved in fatty acid metabolic process. Predicted to act upstream of or within several processes, including energy homeostasis; leptin-mediated signaling pathway; and response to food. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

88 residues, UniProt reviewed canonical sequence.

>Q8N6N7|ACBD7
     1  MALQADFDRA AEDVRKLKAR PDDGELKELY GLYKQAIVGD INIACPGMLD LKGKAKWEAW
    61  NLKKGLSTED ATSAYISKAK ELIEKYGI

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ACBD7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.34
Highest tissue expression
70 nTPM

Expression across tissuesHPA

Tissue

  • amygdala: 70 nTPM
  • basal ganglia: 66 nTPM
  • cerebral cortex: 61 nTPM
  • midbrain: 51 nTPM
  • hippocampal formation: 38 nTPM
  • hypothalamus: 32 nTPM

Single-cell type

  • bergmann glia: 35 nCPM
  • astrocytes: 33 nCPM
  • ependymal cells: 16 nCPM
  • late primary spermatocytes: 16 nCPM
  • fallopian tube ciliated cells: 15 nCPM
  • respiratory ciliated cells: 13 nCPM

Immune cell

  • basophil: 0.7 nTPM
  • neutrophil: 0.7 nTPM
  • plasmacytoid DC: 0.3 nTPM
  • naive B-cell: 0.2 nTPM
  • NK-cell: 0.2 nTPM
  • classical monocyte: 0.1 nTPM

Brain region

  • midbrain: 70 nTPM
  • cerebral cortex: 69 nTPM
  • thalamus: 67 nTPM
  • basal ganglia: 67 nTPM
  • amygdala: 66 nTPM
  • medulla oblongata: 63 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.19
gnomAD pLI
0.12
gnomAD missense Z
0.03
DepMap mean gene effect
0.12
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ACBD7 as an antibody target. Whether an autoantibody or antibody against ACBD7 could matter depends on whether native ACBD7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ACBD7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ACBD7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ACBD7. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...